Tivenix SA and CellCarta Biosciences Announce Expanded Strategic Partnership to Advance Epigenetic Liquid Biopsy Services
Tivenix SA and CellCarta Biosciences Announce Expanded Strategic Partnership to Advance Epigenetic Liquid Biopsy Services. Building on a collaboration initiated in 2025, the partnership expands to encompass clinical development programs in the US and globally, and a joint commercial offering to life sciences clients worldwide. Lugano, Switzerland, 16 October 2026 — Tivenix SA (“Tivenix”), a […]